Align Technology, Inc.
ALGN
Market Cap$14.90B
Volume702.55K
Revenue$3.98B
Gross Profits$2.79B
Employees21200
About
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The Clear Aligner segment offers comprehensive pr...
AI Summary
| Model | Near-Term (0-3 mo.) | Mid-Term (3-12 mo.) | Long-Term (1-5 yr.) |
|---|---|---|---|
| Deepseek | Hold | Buy | Buy |
| OpenAI | Buy | Hold | Buy |
| Gemini | Buy | Hold | Buy |
| Grok | Buy | Hold | Buy |
Detailed Analysis
Deepseek
Holdnear term
Current price above 50-day average but below 200-day average suggests consolidation.
Valuation:Forward PE suggests fair valuation.
Technical:Mixed signals with current price between key averages.
Sentiment:High beta indicates volatility, sentiment could swing.
News:No significant news expected to impact near-term price.
Buymid term
Potential for growth as healthcare sector recovers and if technicals improve.
Valuation:Trailing PEG ratio indicates potential undervaluation for growth.
Technical:If breaks above 200-day average, bullish trend may emerge.
Sentiment:Sector recovery could improve investor sentiment.
News:Innovation in healthcare could provide positive catalysts.
Buylong term
Strong sector fundamentals and company's growth potential support long-term investment.
Valuation:Market cap and sector position support growth valuation.
Technical:Long-term trend likely upward with sector growth.
Sentiment:Positive long-term outlook for healthcare sector.
News:Continued innovation and expansion expected.
Gemini
Buynear term
The stock price is above its 50-day average, indicating positive momentum. Recent price action suggests continued upward trend.
Valuation:Forward P/E suggests reasonable valuation given growth potential.
Technical:Price above 50-day average; bullish short-term trend.
Sentiment:Positive sentiment due to recent price increase.
News:Monitor upcoming earnings reports and product launches.
Holdmid term
While growth is expected, the trailing PEG ratio suggests it may be slightly overvalued. Monitor for continued growth.
Valuation:Trailing PEG ratio indicates possible overvaluation.
Technical:Price near 200-day average; watch for breakout or breakdown.
Sentiment:Neutral sentiment; market awaits further catalysts.
News:Track market share and competitive landscape.
Buylong term
The healthcare sector and ALGN's market position offer long-term growth potential. Monitor for sustained profitability.
Valuation:Long-term growth justifies current valuation.
Technical:Monitor long-term trends and support/resistance levels.
Sentiment:Positive long-term outlook for the healthcare sector.
News:Assess long-term growth strategy and innovation pipeline.
Openai
Buynear term
Current price exceeds short-term averages, indicating upward momentum.
Valuation:Forward PE below sector average, suggesting undervaluation.
Technical:Price above 50-day average, bullish signal.
Sentiment:Market sentiment appears positive, aligning with technical indicators.
News:No recent major news, stable outlook.
Holdmid term
Steady growth expected but market conditions could introduce volatility.
Valuation:Fairly valued with a PEG near 1, suggesting market alignment.
Technical:Approaching 200-day average, caution advised.
Sentiment:Moderate sentiment, watch for shifts in investor confidence.
News:Monitor for any strategic shifts or sector impacts.
Buylong term
Strong fundamentals and sector growth potential support a positive outlook.
Valuation:Attractive long-term valuation with stable earnings growth.
Technical:Long-term trends suggest sustained growth.
Sentiment:Long-term sentiment remains strong on healthcare innovation.
News:Continued innovation and market expansion could drive higher valuations.
Grok
Buynear term
Current price above 50-day average indicates short-term momentum. Positive technicals support near-term growth.
Valuation:Forward P/E of 19.93 suggests reasonable valuation.
Technical:Price above 50-day average signals bullish momentum.
Sentiment:Market sentiment appears neutral to slightly positive.
News:No major negative news impacting near-term outlook.
Holdmid term
Price near 200-day average suggests limited upside. High beta indicates potential volatility.
Valuation:Trailing PEG ratio of 1.08 indicates fair growth pricing.
Technical:Price close to 200-day average shows consolidation.
Sentiment:Mixed sentiment with cautious investor outlook.
News:Healthcare sector stability supports neutral stance.
Buylong term
Strong healthcare sector growth supports long-term potential. Reasonable valuation metrics favor sustained upside.
Valuation:Forward P/E and PEG suggest sustainable growth value.
Technical:Long-term trends depend on broader market conditions.
Sentiment:Positive long-term sentiment for healthcare innovation.
News:Potential for positive developments in dental tech.